alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 31.1

                  CERTIFICATION PURSUANT TO 18 U.S.C. SS. 1350,
      AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Christopher Greenwood, certify that:

1.   I have reviewed this quarterly report on Form 10 QSB of San Jose
     International, Inc.;

2.   Based on my knowledge, this report does not contain any untrue statement of
     a material fact or omit to state a material fact necessary to make the
     statements made, in light of the circumstances under which such statements
     were made, not misleading with respect to the period covered by this
     quarterly report;

3.   Based on my knowledge, the financial statements, and other financial
     information included in this report, fairly present in all material
     respects the financial condition, results of operations and cash flows of
     the registrant as of, and for, the periods presented in this report;

4.   I am responsible for establishing and maintaining disclosure controls and
     procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the
     registrant and I have:

     a)   designed such disclosure controls and procedures to ensure that
          material information relating to the registrant, including its
          consolidated subsidiaries, is made known to us by others within those
          entities, particularly during the period in which this quarterly
          report is being prepared;
     b)   evaluated the effectiveness of the registrant's disclosure controls
          and procedures as of a date within 90 days prior to the filing date of
          this quarterly report (the "Evaluation Date"); and
     c)   presented in this report our conclusions about the effectiveness of
          the disclosure controls and procedures based on our evaluation as of
          the Evaluation Date;

5.   I have disclosed, based on our most recent evaluation, to the registrant's
     auditors and the audit committee of registrant's board of directors (or
     persons performing the equivalent function):

     a)   all significant deficiencies in the design or operation of internal
          controls which could adversely affect the registrant's ability to
          record, process, summarize and report financial data and have
          identified for the registrant's auditors any material weaknesses in
          internal controls; and
     b)   any fraud, whether or not material, that involves management or other
          employees who have a significant role in the registrant's internal
          controls; and

6.   I have indicated in this report whether or not there were significant
     changes in internal controls or in other factors that could significantly
     affect internal controls subsequent to the date of our most recent
     evaluation, including any corrective actions with regard to significant
     deficiencies and material weaknesses.

Date: March 18, 2004


By: /s/ Christopher Greenwood
   --------------------------------
   Christopher Greenwood
   President and CEO
### February 29, 2016

Federal Aviation Administration 600 Independence Avenue S.W. Wilburn Wright Bldg.- Suite 2WIOOO Washington, DC 20591 -., r:



### Attention: Hearing Docket ClerkAGC-430 Re: FAA File No. 2013S0700189 Notice ofAppearance 

### Dear Cleric: 

# !.Frost-n ill6wn**loddu~** ATTORNEYS Winston E Miller Member 502.568.0296 (t) 502.581.1087 (f) wmiller@fbtlaw.com

VIA UPS Overnight and Regular U.S. Mail 

## \=\)(\\2): 1lo ·· 

# Yd. lo \

Pursuant to 14 C.P.R. 13.204, the undersigned hereby gives notice of appearance regarding the above-matter on behalfofUnited Parcel Service, Inc. (an Ohio Corporation, "UPS Ground") and United Parcel Service Co. (a Delaware Corporation, "UPS Airlines"). All communications regarding this matter should be directed to: WinstonE. Miller Frost BrownTodd LLC 400 West Market Street, 32nd Fl. Louisville, KY 40202 502-568-0296 502-581-1087 (Fax) wmiller@futlaw.com Please let me know ifany additional information is needed. Sincerely,
Winston E. 

### Miller Counsel for United Parcel Service, Inc. andUnitedParcel Service Co.

400 West Market Street I 32nd Floor I Louisville, Kentucky 40202-3363 I 502.589.5400 Ifrostbrowntodd.com Offices in Indiana, Kentucky, Ohio, Tennessee, Virginia and West VirginiaFederalAviation Administration Page 2 February 29, 2016

cc: James H. Dunfee, Jr. Enforcement Division, Southern Team 1701 Columbia Avenue College Park, GA 30337 CERTIFICATE OF SERVICE I hereby certify that the foregoing Notice ofAppearance has been sentviaUPS overnight delivery, this 29'h day ofFebruary 2016. Federal Aviation Administration 600 Independence Avenue, SW WilburWright Bldg.- Suite 2Wl000 Washington, DC 20591 Attention: Hearing Docket Clerk (AGC-430) and a copyby certified mail- return receipt requested and regular U.S. mail to: James H. Dunfee, Jr. Enforcement Division, SouthernTeam 1701 ColumbiaAvenue College Park, GA 30337

OOOOOXA.0624664 4838-2395-0126vl Counsel for United Parcel Service, In"2: and United Parcel Service Co.

400 West Market Street 1 32nd Floor I Louisville, Kentucky 40202-3363 I 502.589.5400 Ifrostbrowntodd.com Offices in Indiana, Kentucky, Ohio, Tennessee, Virginia and West Virginia
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS FINANCIAL INFORMATION EXTRACTED FROM THE FINANCIAL
STATEMENTS OF CMI INDUSTRIES INC. FOR THE TWELVE MONTH PERIOD ENDED JANUARY 2,
1999 AND IS QUALIFIED IN ITS ENTIRETY BY SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          JAN-02-1999
<PERIOD-START>                             JAN-03-1998
<PERIOD-END>                               JAN-02-1999
<CASH>                                           3,911
<SECURITIES>                                         0
<RECEIVABLES>                                   52,084
<ALLOWANCES>                                     1,200
<INVENTORY>                                     54,198
<CURRENT-ASSETS>                               116,242
<PP&E>                                         256,265
<DEPRECIATION>                                 159,247
<TOTAL-ASSETS>                                 223,166
<CURRENT-LIABILITIES>                           39,794
<BONDS>                                        124,536
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         1,695
<OTHER-SE>                                      40,388
<TOTAL-LIABILITY-AND-EQUITY>                   223,166
<SALES>                                        412,791
<TOTAL-REVENUES>                               413,804
<CGS>                                          362,216
<TOTAL-COSTS>                                  396,106
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              12,759
<INCOME-PRETAX>                                  4,939
<INCOME-TAX>                                     1,900
<INCOME-CONTINUING>                              3,039
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     3,039
<EPS-PRIMARY>                                     1.79
<EPS-DILUTED>                                     1.79
        

</TABLE>
```

[Congressional Record Volume 158, Number 128 (Thursday, September 20, 2012)]
[House]
[Page H6233]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

            Ms. KAPTUR:
        H.R. 6479.
        Congress has the power to enact this legislation pursuant 
     to the following:
       Article I, Section 8, Clause 4

                          ____________________
```
```

[Federal Register: September 30, 2010 (Volume 75, Number 189)]
[Notices]               
[Page 60464-60465]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr30se10-90]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality

 
Notice of Meeting

    In accordance with section 10(d) of the Federal Advisory Committee 
Act (5 U.S.C., Appendix 2), announcement is made of a Health Care 
Policy and Research Special Emphasis Panel (SEP) meeting.
    A Special Emphasis Panel is a group of experts in fields related to 
health care

[[Page 60465]]

research who are invited by the Agency for Healthcare Research and 
Quality (AHRQ), and agree to be available, to conduct on an as needed 
basis, scientific reviews of applications for AHRQ support. Individual 
members of the Panel do not attend regularly-scheduled meetings and do 
not serve for fixed terms or a long period of time. Rather, they are 
asked to participate in particular review meetings which require their 
type of expertise.
    Substantial segments of the upcoming SEP meeting listed below will 
be closed to the public in accordance with the Federal Advisory 
Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C. 
552b(c)(6). Grant applications for the Advancing Patient Safety with 
Simulation Research Mechanism (R18) applications are to be reviewed and 
discussed at this meeting. These discussions are likely to reveal 
personal information concerning individuals associated with the 
applications. This information is exempt from mandatory disclosure 
under the above-cited statutes.
    SEP Meeting on: Advancing Patient Safety with Simulation Research 
Mechanism (R18).
    Date: November 18-19, 2010 (Open on November 18 from 8:30 a.m. to 
8:45 a.m. and closed for the remainder of the meeting).
    Place: Hilton Washington DC/Rockville Hotel &; Executive Meeting 
Center, 1750 Rockville Pike, Conference Room TBD, Rockville, MD 20852.
    Contact Person: Anyone wishing to obtain a roster of members, 
agenda or minutes of the nonconfidential portions of this meeting 
should contact Mrs. Bonnie Campbell, Committee Management Officer, 
Office of Extramural Research, Education and Priority Populations, 
AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850, Telephone 
(301) 427-1554.
    Agenda items for this meeting are subject to change as priorities 
dictate.

    Dated: September 17, 2010.
Carolyn M. Clancy,
Director.
[FR Doc. 2010-24443 Filed 9-29-10; 8:45 am]
BILLING CODE 4160-90-M
```
EXHIBIT 99.1

                                CERTIFICATION OF
                             CHIEF EXECUTIVE OFFICER
                                   PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Temporary Financial Services, Inc.
(the "Company") on Form 10-QSB for the quarterly period ended March 31, 2004 as
filed with the Securities and Exchange Commission on the date hereof (the
"Report"), I, John R. Coghlan, Chief Executive Officer of the Company, certify,
pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the
Sarbanes-Oxley Act of 2002, that:

      (1) The Report fully complies with the requirements of Section 13(a) or
      15(d) of the Securities Exchange Act of 1934; and

      (2) The information contained in the Report fairly presents, in all
      material respects, the financial condition and results of operations of
      the Company.


/S/ JOHN R. COGHLAN
-------------------

John R. Coghlan

Chief Executive Officer

May 12, 2004
##### 



Exhibit 32.3 CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 The undersigned hereby certifies, in accordance with 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in his
capacity as an officer of Emmis Operating Company (the Company), that, to his
knowledge:  (1)
    
    the Quarterly Report of the Company on Form 10-Q/A for the period
ended November 30, 2003, fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and(2)
    
    the information contained in such report fairly presents, in all
material respects, the financial condition and results of operations
of the Company Date: May 14, 2004 /s/
    
    JEFFREY H. SMULYANJeffrey H. SmulyanChairman of the Board, President and ChiefExecutive Officer
 10
EXHIBIT 10.11

                            SUMMARY OF ORAL AGREEMENT
                 BETWEEN XACT AID, INC. AND TACNA INTERNATIONAL

Our first aid products are manufactured by a third party. The components that
are included in our various products such as bandages, ointments, etc. are
purchased from various vendors and delivered for inclusion in our first aid kits
to our fullfillment (manufacturing) outsource Tacna International, headquartered
in San Diego, California with production facilities in Tijuana, Mexico.

We have no written agreements with Tacna International, however, the following
is a Summary of our oral agreement:

(i)   we ship to Tacna our product components, packaging material and
      instruction inserts;

(ii)  Tacna then forwards such material to their affiliated Mexican company, Mam
      De La Frontera located in Tijuana, Mexico where the products are
      assembled;

(iii) Mam De La Frontera then ships the finished products back to Tacna in San
      Diego for direct shipment to our customers. Assembley charges are billed
      to us at $7.00 per man-hour and the terms of payment are net 45 days.
```

[Congressional Record Volume 158, Number 129 (Friday, September 21, 2012)]
[Extensions of Remarks]
[Page E1584]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

                    IN REMEMBRANCE OF VICTOR CASCIO

                                 ______
                                 

                         HON. RODNEY ALEXANDER

                              of louisiana

                    in the house of representatives

                      Thursday, September 20, 2012

  Mr. ALEXANDER. Mr. Speaker, I rise today to honor the life of Mr. 
Victor Cascio, Sr. His warmhearted connection with those who were 
fortunate to know him and his steadfast involvement in the Monroe, La. 
community will always be remembered.
  Throughout his lifetime, Victor was a vibrant presence in the area. 
He won the hearts of many as a child star on KNOE-TV's ``Happiness 
Exchange,'' and his family has graced Monroe with their superb ability 
as restaurateurs since World War II. The family venture began with his 
late mother Josephine's ``Spaghetti Garden'' and culminating with The 
Chateau, a Louisville Avenue institution, where Victor hosted such 
celebrities as Liberace, Elvis, Donna Douglas of Elly May Clampett 
fame, Danny Thomas, and every Louisiana Governor from Big John 
McKeithen to Bobby Jindal.
  Much of Victor's life was spent in the public eye as a phenomenal 
host, friend, and role model for all, and when he finally closed the 
doors of The Chateau amid an outpouring of support in March of this 
year, it was with the goal of savoring a private life with his wife of 
50 years, Marie.
  Undeniably, the mark he made on our community will never fade. He had 
a gift for putting people at ease and creating an atmosphere that is 
not easily duplicated. In the letter of Saint Paul the Apostle to 
Timothy, (2 Timothy 2:8-13), Paul says ``If we have died with him, we 
shall also live with him; if we persevere, we shall also reign with 
him.'' As we fondly remember the life and accomplishments of Victor, he 
lived in the faith in which he believed.
  To say that he left his fingerprint on the world would be an 
understatement. Victor Cascio brought joy to so many, and he will live 
in our hearts forever.

                          ____________________
```
Exhibit 32.1

CERTIFICATION PURSUANT TO 
18 U.S.C. SECTION 1350, 
AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of GammaCan International Inc. (the Company) on Form 10-QSB for the period ended June 30, 2007 as filed with the Securities and Exchange Commission
on the date hereof (the Report), I, Patrick Schnegelsberg, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. section 906 of the Sarbanes-Oxley Act of 2002, that:

| | (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and                          
| | --- | ---------------------------------------------------------------------------------------------------------------------------------------------------
|
| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
|

|Date: August 14, 2007 |  | By:/s/ PATRICK SCHNEGELSBERG
|--------------------- |  | ----------------------------
|                      |  | Patrick Schnegelsberg       
|                      |  | Chief Executive Officer     

39

---
[Federal Register Volume 89, Number 14 (Monday, January 22, 2024)]
[Notices]
[Page 3926]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-00929]


=======================================================================
-----------------------------------------------------------------------

FEDERAL TRADE COMMISSION


Revised Jurisdictional Thresholds for Section 8 of the Clayton 
Act

AGENCY: Federal Trade Commission.

ACTION: Annual notice of revision.

-----------------------------------------------------------------------

SUMMARY: The Federal Trade Commission announces the revised thresholds 
for interlocking directorates required by the 1990 amendment of Section 
8 of the Clayton Act.

DATES: January 22, 2024.

FOR FURTHER INFORMATION CONTACT: Christopher M. Grengs (202-326-2612), 
Bureau of Competition, Office of Policy and Coordination.

SUPPLEMENTARY INFORMATION: Section 8 of the Clayton Act prohibits, with 
certain exceptions, one person from serving as a director or officer of 
two competing corporations if two thresholds are met. Competitor 
corporations are covered by Section 8 if each one has capital, surplus, 
and undivided profits aggregating more than $10,000,000, with the 
exception that no corporation is covered if the competitive sales of 
either corporation are less than $1,000,000. Section 8(a)(5) requires 
the Federal Trade Commission to revise those thresholds annually, based 
on the change in gross national product. The new thresholds, which take 
effect immediately, are $48,559,000 for Section 8(a)(1), and $4,855,900 
for Section 8(a)(2)(A).
    Authority: 15 U.S.C. 19(a)(5).

April J. Tabor,
Secretary.
[FR Doc. 2024-00929 Filed 1-19-24; 8:45 am]
BILLING CODE 6750-01-P
I 

115TH CONGRESS 

2D SESSION H. R. 5109 

To amend the 21st Century Cures Act to ensure the equitable distribution 

of resources to address the opioid epidemic, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 27, 2018 

Ms. KUSTER of New Hampshire (for herself, Mr. JENKINS of West Virginia, 

Mr. MCKINLEY, Ms. BLUNT ROCHESTER, Mr. POLIQUIN, and Mr. 

COURTNEY) introduced the following bill; which was referred to the Committee on Energy and Commerce 

A BILL 

To amend the 21st Century Cures Act to ensure the equitable distribution of resources to address the opioid epidemic, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Federal Opioid Re5 sponse Fairness Act of 2018’’. 

6 SEC. 2. EQUITABLE DISTRIBUTION OF RESOURCES TO AD7 DRESS THE OPIOID EPIDEMIC. 

8 (a) IN GENERAL.—The second sentence in paragraph 

9 (1) of section 1003(c) of the 21st Century Cures Act 


lotter on DSKBCFDHB2PROD with BILLS
2 

•HR 5109 IH

1 (Public Law 114–255; 42 U.S.C. 290ee–3 note) is amend2 ed by striking ‘‘States with an incidence or prevalence of 

3 opioid use disorders that is substantially higher relative 

4 to other States.’’ and inserting ‘‘States—’’ 

5 ‘‘(A) with a prevalence of opioid use dis6 orders and associated adverse health effects, in7 cluding neonatal abstinence syndrome, that is 

8 substantially higher relative to other States; 

9 and 

10 ‘‘(B) with a per capita prescription opioid, 

11 heroin, or synthetic opioid overdose mortality 

12 rate that is substantially higher relative to 

13 other States.’’. 

14 (b) MINIMUM AMOUNT OF GRANTS.—Section 

15 1003(c) of the 21st Century Cures Act (Public Law 114– 

16 255; 42 U.S.C. 290ee–3 note) is amended by adding at 

17 the end the following new paragraph: 

18 ‘‘(3) MINIMUM AMOUNT OF GRANTS.—Subject 

19 to the availability of appropriations, the amount of 

20 a grant awarded under this subsection shall not be 

21 less than $5,000,000.’’. 

22 (c) TECHNICAL AMENDMENT.—The first sentence in 

23 paragraph (1) of section 1003(c) of the 21st Century 

24 Cures Act (Public Law 114–255; 42 U.S.C. 290ee–3 note) 


lotter on DSKBCFDHB2PROD with BILLS
3 

•HR 5109 IH

1 is amended by striking ‘‘in accordance with subparagraph 

2 (B)’’ and inserting ‘‘in accordance with paragraph (2)’’. 

3 (d) EFFECTIVE DATE.—The amendments made by 

4 subsections (a) and (b) shall take effect on October 1, 

5 2018. 

Æ 


lotter on DSKBCFDHB2PROD with BILLS
[Federal Register Volume 89, Number 10 (Tuesday, January 16, 2024)]
[Notices]
[Page 2630]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-00627]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Biomedical Imaging and Bioengineering; 
Notice of Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting of the 
National Institute of Biomedical Imaging and Bioengineering Special 
Emphasis Panel.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Biomedical Imaging and 
Bioengineering Special Emphasis Panel; Brain Initiative TMM RFA 
Review.
    Date: February 15, 2024.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Democracy II, Suite 920, 
6707 Democracy Blvd., Bethesda, MD 20817 (Virtual Meeting).
    Contact Person: Alexander O. Komendantov, Ph.D., MS, Scientific 
Review Officer, National Institute of Biomedical Imaging and 
Bioengineering, National Institutes of Health, 6707 Democracy Blvd., 
Bethesda, MD 20892, (301) 451-3397, <a href="/cdn-cgi/l/email-protection#7f1e131a071e111b1a0d511410121a111b1e110b10093f11161751181009"><span class="__cf_email__" data-cfemail="92f3fef7eaf3fcf6f7e0bcf9fdfff7fcf6f3fce6fde4d2fcfbfabcf5fde4">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.866, 
National Institute of Biomedical Imaging and Bioengineering, 
National Institutes of Health.)

    Dated: January 9, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-00627 Filed 1-12-24; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>